Amgen has completed its acquisition of Horizon Therapeutics for approximately $27.8 billion. The acquisition was approved by the US Federal Trade Commission (FTC) in...
Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site...
The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...
Contract development and manufacturing organizations (CDMOs) are a crucial part of the life sciences industry. Strangely, despite its current prominence, the CDMO...
With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...
In this interview, Christene Smith sits down with Anne Lamp, the CEO & Co-Founder of Traceless Materials, to delve into the groundbreaking world of natural biopolymer...
